Fig. 5: High DGKZ expression correlates with poor prognosis.

A Immunohistochemical analysis of the expression of DGKZ in TMAs. B, C The correlation of the expression of DGKZ with disease-free survival (DFS) in all patients and TNBC subtypes. D, E The correlation of the expression of DGKZ with overall survival (OS) in all patients and TNBC subtype. F A novel model for the regulation of the TGFβ signaling pathway by DGKZ.